# Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

> **NCT06588517** · PHASE1 · COMPLETED · sponsor: **Overseas Pharmaceuticals, Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Pirfenidone Modified-Release Tablets
- **DRUG:** Pirfenidone Tablets

## Key facts

- **NCT ID:** NCT06588517
- **Lead sponsor:** Overseas Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-08
- **Primary completion:** 2024-04-19
- **Final completion:** 2024-04-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06588517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06588517, "Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06588517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*